Perrigo Company plc
Open
$11.88
Prev. Close
$11.88
High
$11.89
Low
$11.88
Market Snapshot
$1.55B
-1.1
-1.25
$4.37B
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin and currently employs 8,100 full-time employees. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Perrigo Company plc declared a quarterly dividend of $0.29 per share, set for June 16, 2026, for shareholders registered by May 29, 2026.
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin and currently employs 8,100 full-time employees. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Recently from Cashu
Perrigo Company Showcases Consumer Health Commitment at Upcoming UBS Conference
Perrigo Company Strengthens Commitment to Consumer Health at Upcoming Conference Perrigo Company plc, a leading global consumer health provider, prepares to showcase its dedication to enhancing wellne…
Perrigo Enhances Consumer Health Market Strategy Ahead of UBS Global Conference
Perrigo Strengthens Market Position in Consumer Health Sector Perrigo Company plc continues to reinforce its commitment to consumer health with the announcement of President and CEO Patrick Lockwood-T…
Perrigo Company Reports Strong Q4 Growth Driven by OTC Product Demand and Strategic Initiatives
Perrigo Company’s Robust Q4 Performance Highlights Growth Initiatives Perrigo Company plc reports a strong fourth-quarter performance, showcasing resilience in the competitive consumer health market.…
Perrigo Promotes Affordable Healthcare Solutions During National Store Brand Month
Perrigo Champions Accessible Healthcare Solutions During National Store Brand Month Perrigo Company PLC is taking significant strides in promoting accessible healthcare solutions as it celebrates Nati…